SMALL CELL LUNG CANCER (SCLC)
Clinical trials for SMALL CELL LUNG CANCER (SCLC) explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CANCER (SCLC) trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CANCER (SCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail takes on rare, aggressive lung cancer
Disease control Not yet recruitingThis early-stage trial tests whether combining two drugs (lurbinectedin and osimertinib) is safe and can help control a rare lung cancer called transformed small cell lung cancer. About 16 adults whose cancer changed form after initial treatment will take part. The goal is to fin…
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE1, PHASE2 • Sponsor: Misty Shields • Aim: Disease control
Last updated May 26, 2026 07:00 UTC
-
New CAR t therapy targets tough lung cancers in first human trial
Disease control Not yet recruitingThis early-phase study tests a new treatment called ML261 for people with small cell lung cancer or certain neuroendocrine cancers that have come back or stopped responding to standard therapy. ML261 uses a patient's own immune cells, modified to better recognize and attack cance…
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE1 • Sponsor: Moonlight Bio, Inc • Aim: Disease control
Last updated May 26, 2026 06:59 UTC
-
Old drug, new hope: antipsychotic penfluridol tested against tough cancers
Disease control Not yet recruitingThis study tests penfluridol, a drug originally used for mental health, in 33 adults with advanced small cell lung or cervical cancer that has not responded to at least two prior treatments. The goal is to see if it can shrink tumors and control the disease. Participants take the…
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE1, PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 26, 2026 06:47 UTC
-
New combo therapy aims to tame tough lung cancer
Disease control Not yet recruitingThis study tests how well people with small cell lung cancer tolerate a new drug combination: alisertib pills plus paclitaxel chemotherapy. About 50 adults who have already tried at least one prior treatment will take part. The main goal is to check side effects at different dose…
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE2 • Sponsor: Puma Biotechnology, Inc. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for aggressive lung cancer: drug combo plus radiation tested
Disease control Not yet recruitingThis study tests a new treatment for people with extensive-stage small cell lung cancer who have not had prior therapy. The treatment combines the drug bemotuzumab with standard chemotherapy and anlotinib, followed by bemotuzumab, anlotinib, and chest radiation. The goal is to se…
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 22, 2026 13:53 UTC